{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "JPY", "exchange": "JPX", "shortName": "STELLA PHARMA CORPORATION", "longName": "Stella Pharma Corporation", "messageBoardId": "finmb_134106723", "exchangeTimezoneName": "Asia/Tokyo", "exchangeTimezoneShortName": "JST", "gmtOffSetMilliseconds": 32400000, "market": "jp_market", "esgPopulated": false, "regularMarketChangePercent": 2.4024024, "regularMarketPrice": 341.0, "marketState": "CLOSED", "firstTradeDateMilliseconds": 1619049600000, "priceHint": 2, "epsTrailingTwelveMonths": -24.38, "sharesOutstanding": 28676100, "bookValue": 90.982, "fiftyDayAverage": 376.82, "fiftyDayAverageChange": -35.820007, "fiftyDayAverageChangePercent": -0.095058665, "twoHundredDayAverage": 406.135, "twoHundredDayAverageChange": -65.13501, "twoHundredDayAverageChangePercent": -0.16037773, "marketCap": 9778549760, "priceToBook": 3.747994, "sourceInterval": 15, "exchangeDataDelayedBy": 20, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": 8.0, "regularMarketTime": 1683872100, "regularMarketDayHigh": 341.0, "regularMarketDayRange": "328.0 - 341.0", "regularMarketDayLow": 328.0, "regularMarketVolume": 201700, "regularMarketPreviousClose": 333.0, "bid": 337.0, "ask": 341.0, "fullExchangeName": "Tokyo", "financialCurrency": "JPY", "regularMarketOpen": 331.0, "averageDailyVolume3Month": 270012, "averageDailyVolume10Day": 202410, "fiftyTwoWeekLowChange": 30.0, "fiftyTwoWeekLowChangePercent": 0.096463025, "fiftyTwoWeekRange": "311.0 - 624.0", "fiftyTwoWeekHighChange": -283.0, "fiftyTwoWeekHighChangePercent": -0.45352563, "fiftyTwoWeekLow": 311.0, "fiftyTwoWeekHigh": 624.0, "earningsTimestamp": 1685444340, "earningsTimestampStart": 1685444340, "earningsTimestampEnd": 1685444340, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "4888.T"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "ORIX Kouraibashi Building", "address2": "3-2-7 Korai-bashi Chuo-ku", "city": "Osaka", "zip": "541-0043", "country": "Japan", "phone": "81 6 4707 1516", "website": "https://www.stella-pharma.co.jp", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its product includes SPM-011, a boron-containing drug for BNCT for treating head and neck cancer, recurrent malignant glioma and meningioma, and malignant melanoma and angiosarcoma. The company was founded in 2007 and is headquartered in Osaka, Japan.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Tomoyuki  Asano", "title": "Chairman & CEO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Koki  Uehara", "title": "Pres, COO & Director", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}